Rosiglitazone and cardiovascular disease revisited

Med J Aust. 2010 Aug 2;193(3):134-5. doi: 10.5694/j.1326-5377.2010.tb03829.x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone